Go Pro

Versant Venture Management, LLC Top Holdings and 13F Report (2026)

About Versant Venture Management, LLC

Investment Activity

  • Versant Venture Management, LLC has $162.61 million in total holdings as of June 30, 2026.
  • Versant Venture Management, LLC owns shares of 8 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
  • About 7.30% of the portfolio was sold this quarter.
  • This quarter, Versant Venture Management, LLC has purchased 8 new stocks and bought additional shares in 0 stocks.
  • Versant Venture Management, LLC sold shares of 1 stock and completely divested from 0 stocks this quarter.

Largest Holdings

Jade Biosciences, Inc.
$22,037,418
Lenz Therapeutics, Inc.
$15,091,124
Contineum Therapeutics, Inc.
$8,893,673

Largest Sales this Quarter

Jade Biosciences, Inc.
534,037 shares (about $11.87M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofVersant Venture Management, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$76,974,8760.0%3,180,78047.3%Healthcare
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
$29,806,9670.0%12,166,10918.3%Healthcare
Jade Biosciences, Inc.
$22,037,418$11,866,302 â–¼-35.0%991,78313.6%Common Stock
Lenz Therapeutics, Inc.
$15,091,1240.0%2,656,8889.3%Common Stock
Contineum Therapeutics, Inc.
$8,893,6730.0%542,6285.5%Common Stock
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$8,117,2430.0%148,8315.0%Healthcare
Skye Bioscience, Inc.
$1,391,9410.0%2,007,7040.9%Common Stock
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
$299,4470.0%269,7720.2%Healthcare

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data